51 results
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
action arising out of or relating to the Plan and this Option (and agrees not to commence any litigation relating thereto except in such courts … shall be effective service of process for any litigation brought against it in any such court. By accepting this Option, Participant irrevocably
10-Q
2020 Q3
ALGS
Aligos Therapeutics Inc
25 Nov 20
Quarterly report
5:21pm
and enforcing patent claims, including litigation costs and the outcome of such litigation;
the timing, receipt and amount of sales of, or profit share … in litigation or other legal proceedings. While the outcome of any such proceedings cannot be predicted with certainty, as of September 30, 2020, we
424B4
s9r4hvw
1 Jul 21
Prospectus supplement with pricing info
4:31pm
S-1
EX-10.5
u84l6jxxg0b0txtcq
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.5
rtz80gtoa87kf
25 Sep 20
IPO registration
5:27pm
DRS
a553lir nzu
4 Jun 21
Draft registration statement
12:00am
S-1
EX-10.5
71o0d
25 Sep 20
IPO registration
5:27pm